Effects of Adipose Derived Stem Cell Therapy in Women With Premature Ovarian Failure View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2012-2014

ABSTRACT

The purpose of this study is to determine whether Adipose Derived Stem Cells are effective in the treatment of Premature Ovarian Failure (POF). Stem cell transplantation has been reported to rescue ovarian function in a pre-clinical mouse model of chemotherapy-induced POF; however, maintaining the survival of transplanted cells in human ovarian tissues to enable the POF patients regain ovary function over the long-term and achieving a successful pregnancy remain a troublesome issue. In this study the investigators are aiming to determine whether the CD29+/CD44+ human Adipose Derived Stem Cells could later enable ovaries produce mature oocytes. Detailed Description The purpose of this study was to explore the therapeutic potency of the adipose derived stem cells (ADSC) transplantation for premature ovarian failure (POF) women underwent Autologous fat transplantation. The serum of each patient were kept and sent for laboratory test before the surgery. 100ml fat was harvested from the abdomen of POF patient using abdominal fat abortion. And ADSC were isolated and cultured in vitro using autologous serum. The biomarkers of ADSC, CD29 and CD44, were detected in the ADSC cultures using Flow cytometry detection. The ADSC were then transplanted directly into bilateral ovaries when cells reach a density of 5-10×106. The clinical conditions of patients were examined at 1, 2, 4 and 8 weeks after the transplantation. Ovarian functions were evaluated by follicle diameter and sexual hormone levels. The follicle number was counted and radiology data were kept for future analysis. To ensure high rate of pregnancy, intercourse under medical guidance may be suggested and hormone replacement treatment may be taken to help the patients conceive. Main Outcome Measure(s): Serum FSH,LH,E2 levels, recurrence of Menstruation, Antral follicle diameter,and pregnancy. More... »

URL

https://clinicaltrials.gov/show/NCT01853501

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3158", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to determine whether Adipose Derived Stem Cells are effective in the treatment of Premature Ovarian Failure (POF). Stem cell transplantation has been reported to rescue ovarian function in a pre-clinical mouse model of chemotherapy-induced POF; however, maintaining the survival of transplanted cells in human ovarian tissues to enable the POF patients regain ovary function over the long-term and achieving a successful pregnancy remain a troublesome issue. In this study the investigators are aiming to determine whether the CD29+/CD44+ human Adipose Derived Stem Cells could later enable ovaries produce mature oocytes.\n\nDetailed Description\nThe purpose of this study was to explore the therapeutic potency of the adipose derived stem cells (ADSC) transplantation for premature ovarian failure (POF) women underwent Autologous fat transplantation. The serum of each patient were kept and sent for laboratory test before the surgery. 100ml fat was harvested from the abdomen of POF patient using abdominal fat abortion. And ADSC were isolated and cultured in vitro using autologous serum. The biomarkers of ADSC, CD29 and CD44, were detected in the ADSC cultures using Flow cytometry detection. The ADSC were then transplanted directly into bilateral ovaries when cells reach a density of 5-10\u00d7106. The clinical conditions of patients were examined at 1, 2, 4 and 8 weeks after the transplantation. Ovarian functions were evaluated by follicle diameter and sexual hormone levels. The follicle number was counted and radiology data were kept for future analysis. To ensure high rate of pregnancy, intercourse under medical guidance may be suggested and hormone replacement treatment may be taken to help the patients conceive. Main Outcome Measure(s): Serum FSH,LH,E2 levels, recurrence of Menstruation, Antral follicle diameter,and pregnancy.", 
    "endDate": "2014-09-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01853501", 
    "keywords": [
      "adipose", 
      "stem cell therapy", 
      "Primary Ovarian Insufficiency", 
      "stem cell", 
      "stem cell transplantation", 
      "ovarian function", 
      "pre-clinical mouse model", 
      "ovarian failure", 
      "survival", 
      "transplanted cell", 
      "ovarian tissue", 
      "ovary", 
      "successful pregnancy", 
      "mature oocyte", 
      "therapeutic potency", 
      "adipose-derived stem cells", 
      "transplantation", 
      "woman", 
      "serum", 
      "patient", 
      "laboratory", 
      "General Surgery", 
      "abdomen", 
      "abdominal fat", 
      "vitro", 
      "Biological Marker", 
      "CD44", 
      "flow cytometry", 
      "cell", 
      "density", 
      "clinical condition", 
      "follicle", 
      "hormone level", 
      "radiology", 
      "future analysis", 
      "high rate", 
      "pregnancy", 
      "intercourse", 
      "guidance", 
      "hormone replacement", 
      "main outcome measure", 
      "luteinizing hormone", 
      "E2", 
      "Recurrence", 
      "menstruation", 
      "antral follicle"
    ], 
    "name": "Effects of Adipose Derived Stem Cell Therapy in Women With Premature Ovarian Failure", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01853501"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00014.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.428392.6", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.41156.37", 
        "type": "Organization"
      }
    ], 
    "startDate": "2012-09-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1038/labinvest.2012.167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011596266", 
          "https://doi.org/10.1038/labinvest.2012.167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/tp.0b013e3181ca86bb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013015211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/molehr/gar082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013098131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/14653240903350265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031238415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/jpem.2011.339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048521146"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01853501"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01853501'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01853501'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01853501'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01853501'


 

This table displays all metadata directly associated to this object as RDF triples.

86 TRIPLES      16 PREDICATES      68 URIs      55 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01853501 schema:about anzsrc-for:3053
2 anzsrc-for:3158
3 schema:description The purpose of this study is to determine whether Adipose Derived Stem Cells are effective in the treatment of Premature Ovarian Failure (POF). Stem cell transplantation has been reported to rescue ovarian function in a pre-clinical mouse model of chemotherapy-induced POF; however, maintaining the survival of transplanted cells in human ovarian tissues to enable the POF patients regain ovary function over the long-term and achieving a successful pregnancy remain a troublesome issue. In this study the investigators are aiming to determine whether the CD29+/CD44+ human Adipose Derived Stem Cells could later enable ovaries produce mature oocytes. Detailed Description The purpose of this study was to explore the therapeutic potency of the adipose derived stem cells (ADSC) transplantation for premature ovarian failure (POF) women underwent Autologous fat transplantation. The serum of each patient were kept and sent for laboratory test before the surgery. 100ml fat was harvested from the abdomen of POF patient using abdominal fat abortion. And ADSC were isolated and cultured in vitro using autologous serum. The biomarkers of ADSC, CD29 and CD44, were detected in the ADSC cultures using Flow cytometry detection. The ADSC were then transplanted directly into bilateral ovaries when cells reach a density of 5-10×106. The clinical conditions of patients were examined at 1, 2, 4 and 8 weeks after the transplantation. Ovarian functions were evaluated by follicle diameter and sexual hormone levels. The follicle number was counted and radiology data were kept for future analysis. To ensure high rate of pregnancy, intercourse under medical guidance may be suggested and hormone replacement treatment may be taken to help the patients conceive. Main Outcome Measure(s): Serum FSH,LH,E2 levels, recurrence of Menstruation, Antral follicle diameter,and pregnancy.
4 schema:endDate 2014-09-01T00:00:00Z
5 schema:keywords Biological Marker
6 CD44
7 E2
8 General Surgery
9 Primary Ovarian Insufficiency
10 Recurrence
11 abdomen
12 abdominal fat
13 adipose
14 adipose-derived stem cells
15 antral follicle
16 cell
17 clinical condition
18 density
19 flow cytometry
20 follicle
21 future analysis
22 guidance
23 high rate
24 hormone level
25 hormone replacement
26 intercourse
27 laboratory
28 luteinizing hormone
29 main outcome measure
30 mature oocyte
31 menstruation
32 ovarian failure
33 ovarian function
34 ovarian tissue
35 ovary
36 patient
37 pre-clinical mouse model
38 pregnancy
39 radiology
40 serum
41 stem cell
42 stem cell therapy
43 stem cell transplantation
44 successful pregnancy
45 survival
46 therapeutic potency
47 transplantation
48 transplanted cell
49 vitro
50 woman
51 schema:name Effects of Adipose Derived Stem Cell Therapy in Women With Premature Ovarian Failure
52 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01853501
53 schema:sdDatePublished 2019-03-07T15:25
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher Ne5ca83eb9a284f34a9be8101a9ea5f63
56 schema:sponsor https://www.grid.ac/institutes/grid.41156.37
57 https://www.grid.ac/institutes/grid.428392.6
58 schema:startDate 2012-09-01T00:00:00Z
59 schema:subjectOf sg:pub.10.1038/labinvest.2012.167
60 https://doi.org/10.1093/molehr/gar082
61 https://doi.org/10.1097/tp.0b013e3181ca86bb
62 https://doi.org/10.1515/jpem.2011.339
63 https://doi.org/10.3109/14653240903350265
64 schema:url https://clinicaltrials.gov/show/NCT01853501
65 sgo:license sg:explorer/license/
66 sgo:sdDataset clinical_trials
67 rdf:type schema:MedicalStudy
68 Ne5ca83eb9a284f34a9be8101a9ea5f63 schema:name Springer Nature - SN SciGraph project
69 rdf:type schema:Organization
70 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
71 rdf:type schema:DefinedTerm
72 anzsrc-for:3158 schema:inDefinedTermSet anzsrc-for:
73 rdf:type schema:DefinedTerm
74 sg:pub.10.1038/labinvest.2012.167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011596266
75 https://doi.org/10.1038/labinvest.2012.167
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1093/molehr/gar082 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013098131
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1097/tp.0b013e3181ca86bb schema:sameAs https://app.dimensions.ai/details/publication/pub.1013015211
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1515/jpem.2011.339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048521146
82 rdf:type schema:CreativeWork
83 https://doi.org/10.3109/14653240903350265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031238415
84 rdf:type schema:CreativeWork
85 https://www.grid.ac/institutes/grid.41156.37 schema:Organization
86 https://www.grid.ac/institutes/grid.428392.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...